The genome e-volution (Volume 12)

"We have made great progress, but we are still vulnerable and our common commitment to fight global health challenges is not yet strong enough. Despite our knowledge, despite new technologies, without concentrated and global efforts we are limited in our success. Today we see it clearly."...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Kolejni autorzy: European Investment Bank (Redaktor)
Format: Elektroniczne Rozdział
Język:angielski
Wydane: European Investment Bank 2020
Hasła przedmiotowe:
Dostęp online:OAPEN Library: download the publication
OAPEN Library: description of the publication
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000naaaa2200000uu 4500
001 oapen_2024_20_500_12657_47428
005 20210320
003 oapen
006 m o d
007 cr|mn|---annan
008 20210320s2020 xx |||||o ||| 0|eng d
020 |a /doi.org/10.2867/7 
020 |a 9789286146732 
040 |a oapen  |c oapen 
024 7 |a https://doi.org/10.2867/7  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a KFF  |2 bicssc 
100 1 |a European Investment Bank  |4 edt 
700 1 |a European Investment Bank  |4 oth 
245 1 0 |a The genome e-volution (Volume 12) 
260 |b European Investment Bank  |c 2020 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a "We have made great progress, but we are still vulnerable and our common commitment to fight global health challenges is not yet strong enough. Despite our knowledge, despite new technologies, without concentrated and global efforts we are limited in our success. Today we see it clearly." The sequencing of the human genome at the beginning of this millennium marked a new era in biomedicine. Nanotechnology and robotics have created innovative tools and powerful diagnostic techniques. Major therapeutic advances have enabled us to control HIV, and more tailor-made therapies are being implemented to treat cancer. Nonetheless huge challenges remain, not only in the field of cancer, but also with respect to neurodegenerative and other diseases. At the same time, international travel and mobility, as well as globalised trade, are affecting our living conditions and promoting the spread of infectious diseases and new viruses, like the COVID-19 coronavirus, all over the world. The Croatian physician and scientist Ivan Đikić analyses the challenges of contemporary medical research, the emerging threats, like pandemics, and the role played by health systems. This is the twelfth essay in the Big Ideas series created by the European Investment Bank. 
536 |a Knowledge Unlatched 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Finance  |2 bicssc 
653 |a Business & Economics 
653 |a Finance 
856 4 0 |a www.oapen.org  |u https://library.oapen.org/bitstream/id/e2a887c4-01c1-4d23-99f3-7c19cea91bf3/QH0320217ENN.en.pdf  |7 0  |z OAPEN Library: download the publication 
856 4 0 |a www.oapen.org  |u https://library.oapen.org/handle/20.500.12657/47428  |7 0  |z OAPEN Library: description of the publication